Most technological and AI developments in biology never reach patients. I’ve spent my career making sure mine does.
I am the Founder and CEO of Datomics, a stealth Silicon Valley AI biotech building the next generation of personalized cancer medicines.
I started as a software engineer building machine learning models to keep junk and duplicates out of web search results, then earned a PhD in computational biology.
I have spent the last decade advancing AI development and bringing the technology engines behind cancer programs to where they actually count: into the clinic, where the stakes are human lives. This spanned diagnostic tests for early cancer detection based on cell-free DNA in blood, the first-in-human phase I clinical trial of personalized neoantigen-targeted TCR-engineered T cells, and, most recently, a platform that predicts how patients respond to cancer therapy.
The mission across all of them has never moved: make cancer a nonfatal disease.
Feel free to connect with me:
LI: @achursov | FB: @achursov | IG: @achursov | X: @Medicine_30